World City Press – Lifestyle
Author:
AxoSim Inc.
28bio Launches CNS-3D Myelinated Organoids to Predict Therapeutic Efficacy
May 12, 2026
28bio’s Endurance Study Meets Primary Endpoint, Showing CNS-3D Brain Organoids Predict Clinical Seizure Liability
March 23, 2026